So let me get this right. IVX now has the results for 2 cohorts in the LUPUS trial which have had negligible effect but apparently that was to be expected.
Funny I don't recall that ever being mentioned before.
So now IVX will proceed with the final cohorts - plural No mention of the number!
Looks like another cap raising ( which will make 3 that we weren't going to have again) within 6 months at this rate.
Oh but you forget about the other 2 trials I hear you suggest.
I see! You mean the flow of info regarding subjects enrolled, trial progression, interim results that sort of thing.
I must have missed that here under my mushroom.
Call me cynical.
I am trying to work out why Morgans research gave a value of $0.12 per share when the odd asx notice and general lack of info from IVX management has resulted in a price far short of that.
Is it that management aren't good communicators?
Not at meetings I have been at.
In fact they talk up the stock and say things like " We don't expect to have a capital raising again" or " there will be an announcement regarding a partner in a couple of months"
At one meeting when it was said that we would have results by Xmas a shareholder queried "which Xmas?" A little nervous laughter.
Prescient as it turns out!
I am now nervous.
There should be hard questions asked of the management.
What is their agenda?
IVX Price at posting:
6.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)